Roche Tamiflu Reduces Flu Symptom Severity 40% - Swiss Label
Executive Summary
Roche's oral influenza therapy Tamiflu (oseltamivir) was associated with a 40% reduction in the severity of flu symptoms in patients with verified influenza compared to placebo, Swiss labeling reports.
You may also be interested in...
Roche Tamiflu Prevents Flu In More Than 99% Of Frail Elderly - ICAAC
Prophylactic use of Roche's Tamiflu (oseltamivir) reduced the incidence of influenza in an elderly nursing home population to less than 1%, according to preliminary results from a once-daily prevention study presented by Frederick Hayden, MD, University of Virginia, Sept. 27 at the Interscience Conference on Antimicrobial Agents and Chemotherapy in San Francisco.
Roche Tamiflu Prevents Flu In More Than 99% Of Frail Elderly - ICAAC
Prophylactic use of Roche's Tamiflu (oseltamivir) reduced the incidence of influenza in an elderly nursing home population to less than 1%, according to preliminary results from a once-daily prevention study presented by Frederick Hayden, MD, University of Virginia, Sept. 27 at the Interscience Conference on Antimicrobial Agents and Chemotherapy in San Francisco.
Glaxo Relenza Program Will Address Diskhaler Ease of Use, Drug Efficacy
Glaxo plans to monitor patient experience with its Relenza Diskhaler through an "active" Phase IV program for the inhaled antiviral influenza treatment. FDA approved Relenza July 27.